Transcatheter Heart Valves
$3,750.00
The multibillion-dollar transcatheter heart valves market continues to evolve and grow rapidly. We forecast that total sales will increase at a CAGR of 8.4% for the rest of the decade, as minimally invasive therapies gain traction in the management of structural heart disease. Purchase and download our Medtech Market Special Report to receive a detailed market forecast, including sales growth forecasts for the individual companies in the space including Edwards Lifesciences, Medtronic, Abbott and others. This extensive report includes an overview of transcatheter heart valve procedures, technologies and innovations, historical sales and forecast markets, growth rates by region (U.S. and international), competitive analysis/market share, leading competitors and emerging startups, corporate strategies, market drivers and limiters, and trends/opportunities. Carrie Neptune, a veteran medtech market analyst, has produced this report as the latest editorial product from MassDevice, the premier online source of medtech news and insights.
The following is a brief overview from our table of contents:
- Heart valve disease overview
- Transcatheter aortic valve replacement (TAVR) devices
- TAVR’s expansion to low-risk patients
- Transcatheter mitral valve replacement (TMVR) devices
- Transcatheter mitral valve repair (TMVr) devices
- Emerging technology
- Global market forecasts of TAVR, TMVR and TMVr
- TAVR, TMVR and TMVr competitive analysis
Please click on the thumbnails to see the full Table of Contents.
For more information about our Medtech Market Reports, contact Chris Newmarker, MassDevice editor-in-chief, at [email protected]
